GSA Capital Partners LLP cut its stake in The Allstate Co. (NYSE:ALL – Free Report) by 88.5% in the 3rd quarter, Holdings Channel reports. The firm owned 2,063 shares of the insurance provider’s stock after selling 15,859 shares during the period. GSA Capital Partners LLP’s holdings in Allstate were worth $391,000 at the end of the most recent quarter.
Several other large investors have also bought and sold shares of ALL. Allspring Global Investments Holdings LLC lifted its stake in shares of Allstate by 18.7% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 3,000,866 shares of the insurance provider’s stock valued at $569,114,000 after purchasing an additional 472,040 shares during the period. Raymond James & Associates grew its position in shares of Allstate by 10.6% in the 3rd quarter. Raymond James & Associates now owns 1,517,800 shares of the insurance provider’s stock worth $287,851,000 after buying an additional 145,986 shares during the period. Dimensional Fund Advisors LP grew its position in shares of Allstate by 3.4% in the 2nd quarter. Dimensional Fund Advisors LP now owns 1,437,688 shares of the insurance provider’s stock worth $229,545,000 after buying an additional 47,038 shares during the period. Pathway Financial Advisers LLC increased its stake in shares of Allstate by 18,472.5% in the 3rd quarter. Pathway Financial Advisers LLC now owns 1,052,687 shares of the insurance provider’s stock worth $199,642,000 after acquiring an additional 1,047,019 shares in the last quarter. Finally, Hsbc Holdings PLC lifted its position in Allstate by 3.3% during the 2nd quarter. Hsbc Holdings PLC now owns 1,007,953 shares of the insurance provider’s stock valued at $160,948,000 after acquiring an additional 31,789 shares during the period. 76.47% of the stock is owned by institutional investors.
Insider Transactions at Allstate
In related news, insider John E. Dugenske sold 36,367 shares of Allstate stock in a transaction on Friday, September 20th. The stock was sold at an average price of $191.38, for a total transaction of $6,959,916.46. Following the transaction, the insider now directly owns 27,364 shares in the company, valued at approximately $5,236,922.32. The trade was a 57.06 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 1.80% of the company’s stock.
Allstate Stock Performance
Allstate (NYSE:ALL – Get Free Report) last released its quarterly earnings results on Wednesday, October 30th. The insurance provider reported $3.91 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.20 by $1.71. Allstate had a return on equity of 26.67% and a net margin of 6.77%. The business had revenue of $16.63 billion during the quarter, compared to the consensus estimate of $14.57 billion. During the same period in the previous year, the company posted $0.81 EPS. The business’s quarterly revenue was up 14.7% compared to the same quarter last year. On average, equities analysts forecast that The Allstate Co. will post 16.01 earnings per share for the current year.
Allstate Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Thursday, January 2nd. Stockholders of record on Friday, November 29th will be paid a dividend of $0.92 per share. This represents a $3.68 annualized dividend and a dividend yield of 1.81%. The ex-dividend date of this dividend is Friday, November 29th. Allstate’s dividend payout ratio is presently 23.83%.
Analyst Upgrades and Downgrades
A number of equities analysts have weighed in on ALL shares. Roth Mkm reaffirmed a “buy” rating and set a $200.00 target price on shares of Allstate in a research note on Wednesday, August 14th. Raymond James lifted their price objective on Allstate from $205.00 to $220.00 and gave the company a “strong-buy” rating in a research note on Friday, October 4th. Bank of America increased their target price on Allstate from $216.00 to $233.00 and gave the stock a “buy” rating in a research note on Friday, October 18th. Morgan Stanley lifted their price target on Allstate from $220.00 to $228.00 and gave the stock an “overweight” rating in a research report on Thursday, November 7th. Finally, Evercore ISI raised their price objective on shares of Allstate from $191.00 to $195.00 and gave the company an “in-line” rating in a research note on Wednesday, October 9th. One analyst has rated the stock with a sell rating, two have given a hold rating, thirteen have assigned a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, Allstate has a consensus rating of “Moderate Buy” and a consensus price target of $214.19.
Check Out Our Latest Report on ALL
Allstate Company Profile
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.
Further Reading
- Five stocks we like better than Allstate
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- Why Palo Alto Networks’ Multi-Year Uptrend Is Far From Over
- How to Read Stock Charts for Beginners
- 3 Rock-Solid Buying Opportunities in the Market Right Now
- Canadian Penny Stocks: Can They Make You Rich?
- TJX Companies Stock Poised to Hit a New High This Year
Want to see what other hedge funds are holding ALL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Allstate Co. (NYSE:ALL – Free Report).
Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.